Ferdjallah Asmaa, Young Jo-Anne H, MacMillan Margaret L
Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapy, University of Minnesota, Minneapolis, MN, United States.
Department of Medicine, Division of Infectious Disease and International Medicine, Program in Transplant Infectious Disease, University of Minnesota, Minneapolis, MN, United States.
Front Pediatr. 2021 Jul 27;9:634449. doi: 10.3389/fped.2021.634449. eCollection 2021.
Despite major advances in antimicrobial prophylaxis and therapy, opportunistic infections remain a major cause of morbidity and mortality after pediatric hematopoietic cell transplant (HCT). Risk factors associated with the development of opportunistic infections include the patient's underlying disease, previous infection history, co-morbidities, source of the donor graft, preparative therapy prior to the graft infusion, immunosuppressive agents, early and late toxicities after transplant, and graft-vs.-host disease (GVHD). Additionally, the risk for and type of infection changes throughout the HCT course and is greatly influenced by the degree and duration of immunosuppression of the HCT recipient. Hematopoietic cell transplant recipients are at high risk for rapid clinical decompensation from infections. The pediatric intensivist must remain abreast of the status of the timeline from HCT to understand the risk for different infections. This review will serve to highlight the infection risks over the year-long course of the HCT process and to provide key clinical considerations for the pediatric intensivist by presenting a series of hypothetical HCT cases.
尽管在抗菌预防和治疗方面取得了重大进展,但机会性感染仍然是儿童造血细胞移植(HCT)后发病和死亡的主要原因。与机会性感染发生相关的风险因素包括患者的基础疾病、既往感染史、合并症、供体移植物来源、移植前预处理、免疫抑制剂、移植后早期和晚期毒性,以及移植物抗宿主病(GVHD)。此外,在整个造血细胞移植过程中,感染的风险和类型会发生变化,并且受到造血细胞移植受者免疫抑制程度和持续时间的极大影响。造血细胞移植受者因感染而迅速出现临床失代偿的风险很高。儿科重症监护医生必须随时了解造血细胞移植后的时间进程,以了解不同感染的风险。本综述将着重介绍造血细胞移植过程长达一年中的感染风险,并通过一系列假设的造血细胞移植病例,为儿科重症监护医生提供关键的临床考量。